Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2150
https://www.valueinhealthjournal.com/article/S1098-3015(16)33516-1/fulltext
Title : Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33516-1&doi=10.1016/j.jval.2016.09.2150
First page : A722
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2040
Categories :
Tags :
Regions :
ViH Article Tags :